Immune-related adverse events correlate with the clinical efficacy in advanced Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination therapy

Immune-related adverse events correlate with the clinical efficacy in advanced Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination therapy

Abstract Objective The potential of immune-related adverse events (irAEs) in predicting the efficacy of PD-1 inhibitors in advanced non-small-cell lung cancer (NSCLC) has rarely been assessed. This study investigated the associations between irAEs and the clinical efficacy of PD-1 inhibitors combina...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaowan Xie, Yuhao Li, Qiaomei Lv, Wei Wang, Wenbo Ding, Yuanyuan Li
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cancer
Subjects:
Advanced non
Small
Cell lung cancer
PD- 1 inhibitors combination therapy
Immune related adverse events
Clinical efficacy
Online Access:https://doi.org/10.1186/s12885-024-13220-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13220-7

Similar Items